The unexpected link between weight loss drugs and alcohol-related hospital visits
- A new analysis suggests that GLP-1 weight loss drugs, including Wegovy and Mounjaro, could significantly reduce alcohol-related hospital admissions.
- The study, published in BMJ Open, analysed data from 40,703 individuals who began taking semaglutide or tirzepatide between January 2018 and December 2024.
- GLP-1 drugs were associated with a 26 per cent lower risk of alcohol-related hospital admission compared to other diabetes medications.
- Among those using the drugs for weight loss, the risk was 32 per cent lower, while for type 2 diabetics and obese individuals with alcohol problems, reductions were 63 per cent and 65 per cent respectively.
- Researchers suggest a potential role for GLP-1 medications in alcohol use disorder, though experts note that further research is required, particularly given the observational nature of the study and the cost of the drugs.
More bulletins